pamidronate has been researched along with 1,25-dihydroxyergocalciferol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mautalen, C; Pérez Lloret, A; Roldán, EJ; Vega, E | 1 |
Brown, E; Butters, R; Egbuna, O; Goltzman, D; Kantham, L; Pang, J; Pollak, M; Quinn, S | 1 |
1 trial(s) available for pamidronate and 1,25-dihydroxyergocalciferol
Article | Year |
---|---|
Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
Topics: Aged; Alkaline Phosphatase; Body Temperature; Bone and Bones; Calcium; Diphosphonates; Ergocalciferols; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Tablets, Enteric-Coated | 1994 |
1 other study(ies) available for pamidronate and 1,25-dihydroxyergocalciferol
Article | Year |
---|---|
The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone.
Topics: Animals; Calcitonin; Calcium; Calcium, Dietary; Creatinine; Diphosphonates; Duodenum; Ergocalciferols; Gene Expression Regulation; Genotype; Injections, Intraperitoneal; Intestinal Absorption; Kidney; Mice; Mice, Knockout; Pamidronate; Parathyroid Hormone; Phenotype; Receptors, Calcium-Sensing | 2009 |